Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder

Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder

Abstract Background Lisdexamfetamine dimesylate (LDX) has demonstrated safety and efficacy for treatment of Binge Eating Disorder (BED). However, to date, trials have not included participants with co-occurring psychiatric disorders. This study explores how LDX affects eating disorder psychopatholog...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Kristi R. Griffiths, Stephanie Boulet, Sarah Barakat, Stephen Touyz, Phillipa Hay, Sarah Maguire, Michael R. Kohn
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2024-06-01
Sarja:Journal of Eating Disorders
Aiheet:
Mental Health
ADHD
Anxiety
Depression
Psychopharmacology
Pharmacotherapy
Linkit:https://doi.org/10.1186/s40337-024-01041-9

Internet

https://doi.org/10.1186/s40337-024-01041-9

Samankaltaisia teoksia